Michael J. Rybak, PharmD, PhD, MPH

Professor
Eugene Applebaum College of Pharmacy and Health Sciences

Disclosure(s): Abbvie: Grant/Research Support; Innoviva: Grant/Research Support; Melina: Grant/Research Support; Merck: Grant/Research Support; Shionogi: Grant/Research Support

Poster(s):

• (P-1175) Discrepancies Between Bacteriophage Plaque Assays and Time-Kill Analyses in Daptomycin Non-Susceptible Methicillin-Resistant Staphylococcus aureus
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1190) Targeting Phage Defense Mechanisms: Expanding Phage Activity in the Context of Suspected abiF-Mediated Resistance against MRSA
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1210) Real-World Efficacy and Safety of Meropenem-Vaborbactam in Patients with Moderate to Severe Renal Impairment
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1268) Phage Sensitivity Profiles and their Association with Biofilm-mediated Antibiotic Tolerance in DNS-MRSA Isolates
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET